Quick Dispatch:
Your insulin icodec/semaglutide Once-weekly basal insulin analogue in clinical development orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your insulin icodec/semaglutide Once-weekly basal insulin analogue in clinical development ships.
Need Help?
Questions about insulin icodec/semaglutide Once-weekly basal insulin analogue in clinical development, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for insulin icodec/semaglutide Once-weekly basal insulin analogue in clinical development in your area.
FDA rejects Novo Nordisk's weekly basal insulin
26.88
Semaglutide
26.97
Molecular Engineering of Insulin Icodec, the First Acylated Insulin Analog for Once-Weekly Administration in Humans
21.51
Icodec: A Novel Once-Weekly Basal Insulin for Diabetes Management
28.57
Efficacy and safety of once‐weekly insulin icodec versus once‐daily basal insulin in Japanese individuals with type 2 diabetes: A subgroup analysis of the ONWARDS 1, 2 and 4 trials
29.78
FDA Approves Awiqli® — The First Once-Weekly Basal Insulin for Type 2 Diabetes Novo Nordisk announced that on March 26, 2026, the U.S. FDA approved Awiqli® (insulin icodec-abae) 700 units/mL, the first
26.17
Novo Refuses to Give Up on Insulin Icodec, Eyes Combo Filing With Semaglutide
25.78
